Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Lactobacillus helveticus is a probiotic bacterium traditionally used in the production of Swiss and Italian cheeses. In recent years, scientific research has explored its potential benefits for gut health, including the small intestine. Several studies have demonstrated that L. helveticus can survive gastrointestinal transit and colonize the intestines, where it may contribute to maintaining gut barrier integrity and modulating the gut microbiota. It has been shown to produce bioactive peptides with anti-inflammatory and immunomodulatory effects, which may help support the mucosal lining of the small intestine and promote a balanced immune response. Some clinical trials have reported improvements in symptoms of irritable bowel syndrome, relief from mild digestive discomfort, and a reduction in markers of gut inflammation after supplementation with L. helveticus (often in combination with other probiotic strains). However, most evidence comes from animal models or small human studies, and the precise mechanisms by which L. helveticus supports small intestinal health are still being investigated. While there is promising data supporting its use for gut health, more robust, large-scale clinical trials are needed to firmly establish efficacy specifically for the small intestine in humans.

More about lactobacillus helveticus
More about Small Intestines

Other ingredients that support Small Intestines

Other body systems supported by lactobacillus helveticus

Products containing lactobacillus helveticus